Beijing, China - November 24, 2021, minimally invasive Scientific Corporation (hereinafter referred to as "minimally invasive ® Group", 00853.HK) 's Sub Group Shanghai minimally invasive medical robot (Group) Co., Ltd. (hereinafter referred to as " minimally invasive ® robot ", 02252.HK) joint venture known veins (Shanghai) Co., Ltd. robot (hereinafter referred to as" knowledge pulse ") the introduction of the ONE-R ® vascular interventional surgical robot (hereinafter referred to as" ONE-R ® ") in 301 Hospital completed a case of robot-assisted percutaneous coronary intervention (hereinafter referred to as "PCI"). The operation was completed by Professor Chen Yundai, the director of the Department of Cardiology, and his team. Robot-assisted coronary stenting was successfully performed for a patient with acute coronary syndrome.
During the operation, Professor Chen Yundai used remote sensing and buttons behind the radiation protection screen without wearing a lead suit to stably control the robotic arm to smoothly expand the guide wire into the balloon and accurately locate it, and finally put the stent into the stenosis of the heart and blood vessel. Professor Chen Yundai commented: "R-ONE ® is an important milestone in the development of vascular interventions. It can not only accurately place balloons and stents, reduce the amount of radiation received by the surgeon during the operation, but also is easy to use and greatly reduces the doctor’s learning The difficulty of operation makes the whole operation more efficient, safe and green."
R-ONE ® is an innovative robot product deployed by the Minimally Invasive ® robot on the pan-vascular circuit. It is a vascular interventional navigation control system based on master-slave control technology, which can assist cardiovascular interventionists to achieve higher-precision surgical operations. Reduce the X-ray radiation dose received by the surgeon. R-ONE ® uses robotic arm assisted operations to accurately locate lesions, with stronger guidance, stricter judgment on diseased blood vessels, optimization of balloon and stent catheter delivery, standardization of surgical procedures, and reduction of surgical complications. In traditional vascular interventional surgery, the surgeon needs to be exposed to X-ray ionizing radiation for a long time, and long-term wearing of heavy lead clothes can easily damage the skeletal system of the surgeon.
Zhimai (Shanghai) Robotics Co., Ltd. is a joint venture company established in China by Shanghai Minimally Invasive Medical Robotics (Group) Co., Ltd. and French Robocath SAS. Dr. Philippe Bencteux, Chairman and Founder of Robocath, said: " The first registered clinical trial completed by R-ONE ® in China is the result of the combination of Robocath and MicroPort ® robots and a win-win cooperation. I am also very grateful to Professor Chen Yundai and the Zhimai team. Efforts. This clinical trial has taken the first step in the popularization of robot-assisted PCI surgery. The precise and efficient workflow of vascular interventional surgery robots will subvert traditional surgical procedures, improve patient safety, and provide clinicians with safer Working environment, I look forward to R-ONE ® can continue to create new milestones."
Minimally invasive ® robot for minimally invasive surgery Group is committed to the forefront of development needs, providing innovative and remodeling can prolong the life of intelligent robotic surgery program full solution. At present, the group's research products and international cooperation products cover the five "golden tracks" of endoscopy, orthopedics, pan-vascular, transnatural cavity, and percutaneous puncture surgical robots. Minimally invasive ® robot president Dr. He Chao expressed: "R-ONE ® vascular interventional surgical robot to complete the first case of registered clinical trials of percutaneous coronary intervention is minimally invasive ® an important milestone for pan-vascular Robotics robots currently there is not yet listed. With the clinical development and subsequent certification of R-ONE ® , similar products will fill the gap in the field of domestic percutaneous coronary intervention surgery robots and bring good news to doctors and patients."
https://www.microport.com.cn/news/2334.html
